Apealea União Europeia - italiano - EMA (European Medicines Agency)

apealea

inceptua ab - paclitaxel - neoplasie ovariche - antineoplastic agents, taxanes - apealea in combinazione con carboplatino è indicato per il trattamento di pazienti adulti con prima recidiva platino‑sensibile cancro epiteliale ovarico, cancro peritoneale primario e di tuba di falloppio cancro.

Carboplatin-Teva 50 mg / 5 ml Infusionslösung Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin-teva 50 mg / 5 ml infusionslösung

Carboplatin-Teva 50 mg / 5 ml Solution à diluer pour perfusion Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin-teva 50 mg / 5 ml solution à diluer pour perfusion

Carboplatin-Teva 150 mg / 15 ml Infusionslösung Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin-teva 150 mg / 15 ml infusionslösung

Carboplatin-Teva 150 mg / 15 ml Solution à diluer pour perfusion Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin-teva 150 mg / 15 ml solution à diluer pour perfusion

Carboplatin-Teva 450 mg / 45 ml Infusionslösung Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin-teva 450 mg / 45 ml infusionslösung

Carboplatin-Teva 450 mg / 45 ml Solution à diluer pour perfusion Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin-teva 450 mg / 45 ml solution à diluer pour perfusion

Carboplatin Sandoz 50 mg/5 ml Infusionslösung Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin sandoz 50 mg/5 ml infusionslösung

Carboplatin Sandoz 50 mg/5 ml Solution à diluer pour perfusion Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin sandoz 50 mg/5 ml solution à diluer pour perfusion

Carboplatin Sandoz 150 mg/15 ml Infusionslösung Suíça - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

carboplatin sandoz 150 mg/15 ml infusionslösung